Quick Answer
AVENUE THERAPEUTICS, INC. reported Earnings Per Share Diluted of $0.22 (loss) per share for the year ending 2021.
- AVENUE THERAPEUTICS, INC. showed an increase of +29.0% in Earnings Per Share Diluted from 2020 to 2021.
- This data is from AVENUE THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 25, 2022.
- XBRL data for this metric is available from 2020 to 2021 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $0.06 (loss) per share | Q1 2021: $0.06 (loss) per share | Q2 2021: $0.06 (loss) per share | Q3 2021: $0.79 (loss) per share | Q1 2022: $0.14 (loss) per share | Q2 2022: $0.03 (loss) per share | Q3 2022: $0.45 (loss) per share | Q3 2023: $0.06 per share.
- Historical annual values: Fiscal year 2021: $0.22 (loss) per share | Fiscal year 2020: $0.31 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: